Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Capital Leases (2016 - 2017)

Historic Capital Leases for Ekso Bionics Holdings (EKSO) over the last 3 years, with Q1 2017 value amounting to $125000.0.

  • Ekso Bionics Holdings' Capital Leases fell 3932.04% to $125000.0 in Q1 2017 from the same period last year, while for Mar 2017 it was $125000.0, marking a year-over-year decrease of 3932.04%. This contributed to the annual value of $226000.0 for FY2015, which is N/A changed from last year.
  • According to the latest figures from Q1 2017, Ekso Bionics Holdings' Capital Leases is $125000.0, which was down 3932.04% from $166000.0 recorded in Q3 2016.
  • In the past 5 years, Ekso Bionics Holdings' Capital Leases ranged from a high of $226000.0 in Q4 2015 and a low of $125000.0 during Q1 2017
  • For the 3-year period, Ekso Bionics Holdings' Capital Leases averaged around $181800.0, with its median value being $186000.0 (2016).
  • The largest annual percentage gain for Ekso Bionics Holdings' Capital Leases in the last 5 years was 3932.04% (2017), contrasted with its biggest fall of 3932.04% (2017).
  • Ekso Bionics Holdings' Capital Leases (Quarter) stood at $226000.0 in 2015, then dropped by 26.55% to $166000.0 in 2016, then decreased by 24.7% to $125000.0 in 2017.
  • Its last three reported values are $125000.0 in Q1 2017, $166000.0 for Q3 2016, and $186000.0 during Q2 2016.